Related Experiment Video
Updated: Aug 18, 2026

Early Detection of Drug-Induced Renal Hemodynamic Dysfunction Using Sonographic Technology in Rats
Published on: March 11, 2016
Identification and measurement of genomic biomarkers of nephrotoxicity
1Department of Genetic and Molecular Toxicology, Schering-Plough Research Institute, 144 Route 94, Lafayette, NJ 07871, USA. federico.goodsaid@fluidigm.com
Abstract:
An accelerated pace for drug discovery and development requires the application of measurements of novel parameters for drug-induced toxicity. Genomic biomarkers can contribute to this process as indicators or predictors of toxicity. Transcript levels for genes such as the kidney injury molecule have been identified and evaluated as genomic biomarkers of nephrotoxicity.
Insights
Genomic biomarkers, like kidney injury molecule transcript levels, can predict drug-induced toxicity. This aids in accelerating drug discovery and development by identifying potential kidney damage early.
Area of Science:
- Pharmacogenomics
- Toxicology
- Biomarker Discovery
Background:
- Drug discovery necessitates novel toxicity measurements.
- Genomic biomarkers offer potential for predicting drug toxicity.
- Early identification of toxicity is crucial for drug development.
Purpose of the Study:
- To explore the utility of genomic biomarkers in predicting drug-induced toxicity.
- To evaluate transcript levels of specific genes as indicators of nephrotoxicity.
Main Methods:
- Analysis of gene transcript levels.
- Identification and evaluation of potential genomic biomarkers.
- Focus on genes related to kidney injury.
Main Results:
- Transcript levels for kidney injury molecule genes were identified.
- These transcript levels show potential as genomic biomarkers for nephrotoxicity.
Conclusions:
- Genomic biomarkers, specifically kidney injury molecule transcript levels, can serve as predictors of drug-induced nephrotoxicity.
- Utilizing such biomarkers can enhance the efficiency of drug discovery and development.
Related Concept Videos
Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
Pharmacogenomics: Identification of New Drug Targets
Nephrotic Syndrome II : Assessment and Medical Management
Serum Studies: Renal Function Tests
Acute Kidney Injury IV: Diagnostic Studies and Prevention

